Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
US9393280B2 · kind B2 · utility
0Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2012 |
| Grant date | Jul 19, 2016 |
| Priority date | — |
| Expiry date | Nov 4, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides formulations containing sanguinarine, chelerythrine or chelidonine or their salts or extracts containing them, mixed with suitable vehicles and/or excipients, for the treatment of common skin warts and verrucas, anal and vulvar warts and psoriatic plaques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.